Please use this identifier to cite or link to this item:
https://doi.org/10.3389/fimmu.2022.1041362
| Title: | Editorial: Next generation γδ T cell-based tumor immunotherapy | Authors: | Tan, AHM Cheung, AMS Kabelitz, D |
Keywords: | butyrophilins chimeric antigen receptor-engineered gamma delta T cells cost-effective manufacturing of gamma delta t cell therapies cytokine programming gamma delta (γδ) T cells gamma delta TCR repertoire phosphoantigens tumor immunotherapy Humans Immunotherapy Neoplasms Receptors, Antigen, T-Cell, gamma-delta |
Issue Date: | 30-Sep-2022 | Publisher: | Frontiers Media SA | Citation: | Tan, AHM, Cheung, AMS, Kabelitz, D (2022-09-30). Editorial: Next generation γδ T cell-based tumor immunotherapy. Frontiers in Immunology 13 : 1041362-. ScholarBank@NUS Repository. https://doi.org/10.3389/fimmu.2022.1041362 | Source Title: | Frontiers in Immunology | URI: | https://scholarbank.nus.edu.sg/handle/10635/248814 | ISSN: | 1664-3224 | DOI: | 10.3389/fimmu.2022.1041362 |
| Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
| File | Description | Size | Format | Access Settings | Version | |
|---|---|---|---|---|---|---|
| Editorial Next generation γδ T cell-based tumor immunotherapy.pdf | Published version | 291.42 kB | Adobe PDF | OPEN | Published | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.